The FSA's decision to restrict the sale of traded life policy investments (TPLIs) looks likely to spread to other alternative investments, according to a law firm and life settlement trade body.
This week the regulator announced it had found "significant problems with the way in which TLPIs are designed, marketed and sold", and that further regulation was a possibility. But the FSA had been "woefully ineffective" in the way it had carried out the investigation into the asset class and protected consumers, said Michael Wainwright, partner at law firm Eversheds. "If the FSA is not careful, it will unleash yet another wave of compensation claims that, coming on top of the Keydata scandal, could wipe out a significant part of the financial adviser sector," he said. The issue w...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
